Financhill
Back

GT Biopharma, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTBP is experiencing buying pressure, which is a positive indicator for future bullish movement.

GT Biopharma, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.73 Buy
20-day SMA: 0.71 Buy
50-day SMA: 0.69 Buy
200-day SMA: 1.67 Sell
8-day EMA: 0.75 Buy
20-day EMA: 0.72 Buy
50-day EMA: 0.75 Buy
200-day EMA: 1.53 Sell

GT Biopharma, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 62.95 Buy
Chaikin Money Flow: 1491834 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.65 - 0.77) Buy
Bollinger Bands (100): (0.54 - 1.18) Sell

GT Biopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for GT Biopharma, Inc. Stock

Is GT Biopharma, Inc. Stock a Buy?

GTBP Technical Analysis vs Fundamental Analysis

Sell
38
GT Biopharma, Inc. (GTBP) is a Sell

Is GT Biopharma, Inc. a Buy or a Sell?

GT Biopharma, Inc. Stock Info

Market Cap:
9M
Price in USD:
0.85
Share Volume:
1.5M

GT Biopharma, Inc. 52-Week Range

52-Week High:
3.85
52-Week Low:
0.54
Sell
38
GT Biopharma, Inc. (GTBP) is a Sell

GT Biopharma, Inc. Share Price Forecast

Is GT Biopharma, Inc. Stock a Buy?

  • GT Biopharma, Inc. share price is 0.85 while GTBP 8-day exponential moving average is 0.75, which is a Buy signal.
  • The stock price of GTBP is 0.85 while GT Biopharma, Inc. 20-day EMA is 0.72, which makes it a Buy.
  • GT Biopharma, Inc. 50-day exponential moving average is 0.75 while GTBP share price is 0.85, making it a Buy technically.
  • GTBP stock price is 0.85 and GT Biopharma, Inc. 200-day simple moving average is 1.53, creating a Sell signal.

Fundamental Analysis of GT Biopharma, Inc.

Is GT Biopharma, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.93 per share.

Technical Analysis of GT Biopharma, Inc.

Should I short GT Biopharma, Inc. stock?

* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.